| Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007–08 P Lumbiganon, M Laopaiboon, AM Gülmezoglu, JP Souza, ... The Lancet 375 (9713), 490-499, 2010 | 1722 | 2010 |
| Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double … M Lehtinen, J Paavonen, CM Wheeler, U Jaisamrarn, SM Garland, ... The lancet oncology 13 (1), 89-99, 2012 | 897 | 2012 |
| HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients X Castellsagué, L Alemany, M Quer, G Halec, B Quirós, S Tous, ... Journal of the National Cancer Institute 108 (6), djv403, 2016 | 782 | 2016 |
| Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study U Jaisamrarn, X Castellsague, SM Garland, P Naud, J Palmroth, ... PloS one 8 (11), e79260, 2013 | 189 | 2013 |
| World Health Organization Global Survey on Maternal and Perinatal Health Research Group. Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal … P Lumbiganon, M Laopaiboon, AM Gülmezoglu, JP Souza, ... Lancet 375 (9713), 490-499, 2010 | 188 | 2010 |
| Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer G Halec, L Alemany, B Lloveras, M Schmitt, M Alejo, FX Bosch, S Tous, ... The Journal of pathology 234 (4), 441-451, 2014 | 154 | 2014 |
| Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post‐hoc … SM Garland, J Paavonen, U Jaisamrarn, P Naud, J Salmerón, SN Chow, ... International journal of cancer 139 (12), 2812-2826, 2016 | 133 | 2016 |
| Effectiveness of a clinically integrated e-learning course in evidence-based medicine for reproductive health training: a randomized trial R Kulier, AM Gülmezoglu, J Zamora, MN Plana, G Carroli, JG Cecatti, ... Jama 308 (21), 2218-2225, 2012 | 97 | 2012 |
| Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control … X Castellsagué, P Naud, SN Chow, CM Wheeler, MJV Germar, ... The Journal of infectious diseases 210 (4), 517-534, 2014 | 71 | 2014 |
| Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial X Castellsagué, J Paavonen, U Jaisamrarn, CM Wheeler, SR Skinner, ... BMC infectious diseases 14, 1-12, 2014 | 55 | 2014 |
| HPV PATRICIA Study Group: Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of … M Lehtinen, J Paavonen, CM Wheeler, U Jaisamrarn, SM Garland, ... Lancet Oncol 13 (1), 89-99, 2012 | 38 | 2012 |
| Post Hoc Analysis of the PATRICIA Randomized Trial of the Efficacy of Human Papillomavirus Type 16 (HPV-16)/HPV-18 AS04-Adjuvanted Vaccine against … F Struyf, B Colau, CM Wheeler, P Naud, S Garland, W Quint, SN Chow, ... Clinical and Vaccine Immunology 22 (2), 235-244, 2015 | 24 | 2015 |
| A cluster randomized controlled trial to evaluate the effectiveness of the clinically integrated RHL evidence-based medicine course R Kulier, KS Khan, AM Gulmezoglu, G Carroli, JG Cecatti, MJ Germar, ... Reproductive Health 7, 1-9, 2010 | 16 | 2010 |
| Breast and cervical cancer screening in the Philippines: Challenges and steps forward FDV Ho, MVPN Arevalo, PTS de Claro, LE Jacomina, MJV Germar, ... Preventive Medicine Reports 29, 101936, 2022 | 12 | 2022 |
| ICO International HPV in Head and Neck Cancer Study Group (2016). HPV involvement in head and neck cancers: Comprehensive assessment of biomarkers in 3680 patients X Castellsagué, L Alemany, M Quer, G Halec, B Quirós, S Tous, ... Journal of the National Cancer Institute 108 (6), 2016 | 12 | 2016 |
| Prioritising access to cancer drugs CVM Puyat, MAB Eala, EC Dee, OAG Tantengco, ARDP Cruz, ... The Lancet Oncology 23 (1), e2, 2022 | 7 | 2022 |
| Cost-effectiveness analysis of AS04-adjuvanted human papillomavirus 16/18 vaccine compared with human papillomavirus 6/11/16/18 vaccine in the Philippines, with the new 2-dose … MJ Germar, C Purugganan, MS Bernardino, B Cuenca, YC Chen, X Li, ... Human Vaccines & Immunotherapeutics 13 (5), 1158-1166, 2017 | 7 | 2017 |
| Correction: Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study U Jaisamrarn, X Castellsagué, SM Garland, P Naud, J Palmroth, ... PLoS One 8 (12), 2013 | 5 | 2013 |
| HPV mRNA testing in cervical cancer screening: implications for low and middle-income countries MD Ton, NS Swami, MJV Germar, EC Dee International journal of gynecological cancer: official journal of the …, 2022 | 1 | 2022 |
| Contraceptive use and factors associated with unmet need for family planning among postpartum women admitted in a tertiary hospital. 11 JIR Argel, MJV Germar Philippine Journal of Obstetrics and Gynecology, 1-11, 2020 | 1 | 2020 |
